Metrics manifesting the strongest concurrent validity with providers identified from these records related to those who co-prescribed benzodiazepines (e.g., valium) and high levels of opioid analgesics (e.g., oxycodone), as well as those who wrote temporally overlapping prescriptions. The report concludes with a discussion of a variety of uses to which these metrics may be put, as well as problems and opportunities related to their use. (Publisher abstract modified)
Downloads
Similar Publications
- Differentiation of the 1-(Methylenedioxyphenyl)-2-Piperazinopropanes and 1-(Methoxyphenyl)-2-Piperazinopropanones by GC-IRD and GC-MS
- Visual Imagery Ability and Multitrial Picture Recognition With Variant Verses Identity Cues
- Developing and Using a Serious Drug Abuser Scale in the Criminal Justice System: Executive Summary